Pharmaceutical main Mankind Pharma reported a 21 per cent year-on-year rise in internet revenue, with income rising 12 per cent year-on-year within the second quarter of fiscal 12 months 2024 (Q2FY24) in a regulatory submitting final week. In an electronic mail interview with Enterprise Commonplace, Rajeev Junejasays Vice President and Managing Director of Mankind Pharma Sanket Cole On the explanations behind the corporate’s weak progress within the client healthcare phase and its combined efficiency within the acute and persistent segments within the second quarter. Edited excerpts:
Why did Mankind face weak progress within the client healthcare sector within the September quarter?
Humanity’s client healthcare phase confronted subdued progress in Q2 FY24, registering a 2 per cent year-on-year enhance to Rs 193 lakh.
First printed: November 12, 2023 | 3:27 pm he
(Tags for translation)Human Pharma